Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Recent reports of secondary acute myelogenous leukemia (AML) occurring in children previously treated for acute lymphoblastic leukemia (ALL) prompted a review of patients with ALL treated at the Dana Farber Cancer Institute consortium (DFCI) between 1973 and 1987. Seven hundred fifty-two of 779 children treated for ALL entered complete remission. The mean follow-up time for the 752 patients was 4.4 years. Two children had AML develop 12 and 13 months after the diagnosis of ALL, respectively.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cancer

Title: Cancer

Publisher: Wiley

ISSN: 0008-543X

ISSN (Print): 0008-543X

Publication date (Electronic): Oct 15 1992

Volume: 70

Issue: 8

Affiliations

[1 ] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Article

DOI: 10.1002/1097-0142(19921015)70:8<2208::aid-cncr2820700832>3.0.co;2-p

PubMed ID: 1394053

SO-VID: bb785e2c-d8a6-436d-af5a-008f9bddcba8

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1

Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report
Authors: Xiaoning Wang, Ding Ding, Yalin Liu

See all cited by